JDBRX
Price
$45.73
Change
+$0.06 (+0.13%)
Updated
May 22 closing price
Net Assets
25.07B
RLBEX
Price
$34.84
Change
+$0.03 (+0.09%)
Updated
May 22 closing price
Net Assets
237.69B
Interact to see
Advertisement

JDBRX vs RLBEX

Header iconJDBRX vs RLBEX Comparison
Open Charts JDBRX vs RLBEXBanner chart's image
Janus Henderson Balanced R
Price$45.73
Change+$0.06 (+0.13%)
VolumeN/A
Net Assets25.07B
American Funds American Balanced R4
Price$34.84
Change+$0.03 (+0.09%)
VolumeN/A
Net Assets237.69B
JDBRX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDBRX vs. RLBEX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 238B vs. JDBRX (25.1B). RLBEX pays higher dividends than JDBRX: RLBEX (1.98) vs JDBRX (1.40). JDBRX was incepted earlier than RLBEX: JDBRX (16 years) vs RLBEX (23 years). JDBRX (1.31) is less costly to investors than RLBEX (0.59). JDBRX is a more actively managed with annual turnover of: 76.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than JDBRX: RLBEX (250) vs JDBRX (2500). RLBEX annual gain was more profitable for investors over the last year : 4.75 vs. JDBRX (3.48). RLBEX (38.04) and JDBRX (37.65) have equivalent 5 years return.
JDBRXRLBEXJDBRX / RLBEX
Total Expense Ratio1.310.59222%
Annual Report Gross Expense Ratio1.310.59222%
Fund Existence16 years23 years-
Gain YTD1.4841.97675%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.1B238B11%
Annual Yield % from dividends1.401.9871%
Returns for 1 year3.484.7573%
Returns for 3 years23.9822.57106%
Returns for 5 years37.6538.0499%
Returns for 10 years64.1854.30118%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PENN14.660.46
+3.24%
PENN Entertainment
AHH6.82N/A
N/A
Armada Hoffler Properties
INDP0.38N/A
N/A
Indaptus Therapeutics
NBIX119.12-1.44
-1.19%
Neurocrine Biosciences
ZENV1.25-0.06
-4.58%
Zenvia